Organization | Hospital Universitario San Ignacio

Hospital Universitario San Ignacio Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Bogotá Colombia (1942)

Organization Overview

First Clinical Trial

2014

NCT02998489

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Hospital Universitario San Ignacio

Active Ingredients

Drugs in Phase 4 Trials (1)

metoclopramide (reglan) (1 trial)

Drugs in Phase 3 Trials (12)

azithromycin (zithromax) (1 trial)

Caesalpinia spinosa (3 trials)

emtricitabine (emtriva) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

hypochlorous acid (1 trial)

insulin aspart (Novolog) (1 trial)

insulin degludec (tresiba) (1 trial)

insulin glargine (toujeo) (1 trial)

liraglutide (victoza) (1 trial)

lopinavir (Kaletra) (1 trial)

ritonavir (Norvir) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Phase 2 Trials (1)

petiveria alliacea (1 trial)

Drugs in Other Trials (1)

cow milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronavirus Infections (Phase 3)

Esophagitis, Peptic (Phase 4)

Gastroesophageal Reflux (Phase 4)

Infections (Phase 3)

Premature Birth (Phase 4)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 15